Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2026-05-21 @ 9:05 AM
Study NCT ID:
NCT05164458
Status:
RECRUITING
Last Update Posted:
2023-12-28
First Post:
2021-11-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of IBI389 Single Agent, and in Combination With Sintilimab, in Patients With Advanced Malignancies
Sponsor:
Organization: